![]() ![]() Resources for Transgender Youth and Their FamiliesĬhristopher Cheng-Yu Liu, M.D., is a pediatric otolaryngologist at Children’s Health℠ and Assistant Professor of Otolaryngology – Head and Neck Surgery at UT Southwestern.Pediatric Clinical Trials & Experimental Medication.Nursing Transition to Practice Programs.Child Life and Music Therapy Training Opportunities.Fellowship and Subspecialty Training Programs.doi: 10.1126/’s Health is proud to become the first pediatric health system in the country to offer Amazon Lockers, self-service kiosks that allow you to pick up your Amazon packages when and where you need them most – 24 hours a day, seven days a week. ![]() mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice. The tuberous sclerosis complex-mammalian target of rapamycin pathway maintains the quiescence and survival of naive T cells. Wu Q, Liu Yu, Chen C, Ikenoue T, Qiao Y, Li CS, Li W, Guan KL, Liu Y, Zheng P. Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition. doi: 10.1016/j.ccr.2014.03.016.Ĭhen C, Liu Yu, Lu C, Cross JR, Morris JP 4th, Shroff AS, Ward PS, Bradner JE, Thompson C, Lowe SW. ML元 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. doi: 10.1016/j.molcel.2014.12.034.Ĭhen C, Liu Yu, Rappaport AR, Kitzing T, Schultz N, Zhao Z, Shroff AS, Dickins RA, Vakoc CR, Bradner JE, Stock W, LeBeau MM, Shannon KM, Kogan S, Zuber J, Lowe SW. An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation. Ye P*, Liu Yu*, Chen C, Tang F, Wu Q, Wang X, Liu CG, Liu X, Liu R, Liu Y, Zheng P. Identifying a confused cell identity for esophageal squamous cell carcinoma. Pan X, Wang J, Guo L, Na F, Du J, Chen X, Zhong A, Zhao L, Zhang L, Zhang M, Wan X, Wang M, Liu H, Dai S, Tan P, Chen J, Liu Yu#, Hu B#, Chen C#. Epigenetic drug library screening identified an LSD1 inhibitor to target UTX-deficient cells for differentiation therapy. Wu B, Pan X, Chen X, Chen M, Shi K, Xu J, Zheng J, Niu T, Chen C#, Shuai X#, Liu Yu#. Nivolumab treatment of relapsed/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults. Liu P*, Pan X*, Chen C, Niu T, Shuai X, Wang J, Chen X, Liu J, Guo Y, Xie L, Wu Y, Liu Yu#, Liu T#. ![]() Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. Liu Yu*, Chen C*, Xu Z, Scuoppo C, Rillahan CD, Gao J, Spitzer B, Bosbach B, Kastenhuber ER, Baslan T, Ackermann S, Cheng L, Wang Q, Niu T, Schultz N, Levine RL, Mills AA, Lowe SW. An Epigenetic Mechanism Underlying Chromosome 17p Deletion-Driven Tumorigenesis. 2022 Sep 12 40(9):1044-1059.e8.Ĭhen M*, Chen X*, Li S, Pan X, Gong Y, Zheng J, Xu J, Zhao C, Zhang Q, Zhang S, Qi L, Wang Z, Shi K, Ding BS, Xue Z, Chen L, Yang S, Wang Y, Niu T, Dai L, Lowe SW, Chen C#, Liu Yu#. Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer. Wang M#, Chen X#, Tan P#, Wang Y#, Pan X, Lin T, Jiang Y, Wang B, Xu H, Wang Y, Yang Y, Wang J, Zhao L, Zhang J, Zhong A, Peng Y, Du J, Zhang Q, Zheng J, Chen J, Dai S, Na F, Lu Z, Liu J, Zheng X, Yang L, Zhang P, Han P, Gong Q, Zhong Q, Xiao K, Yang H, Deng H, Zhao Y, Shi H, Man J, Gou M, Zhao C, Dai L, Xue Z, Chen L, Wang Y, Zeng M, Huang C, Wei Q*, Wei Y, Liu Y*, Chen C*. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |